GSK’s Second Flu Vaccine Would Boost Capacity To 30 Mil. Doses
This article was originally published in The Pink Sheet Daily
Executive Summary
GSK submits a BLA for FluLaval, acquired as part of its 2005 purchase of ID Biomedical, to FDA March 23.